Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer.
Guedea F, Aguilo F, Polo A, Langley S, Laing R, Henderson A, Aaltomaa S, Kataja V, Palmgren J, Bladou F, Salem N, Gravis G, Losa A, Guazzoni G, Nava L.
Guedea F, et al. Among authors: polo a.
Radiother Oncol. 2006 Jul;80(1):57-61. doi: 10.1016/j.radonc.2006.06.004. Epub 2006 Jul 10.
Radiother Oncol. 2006.
PMID: 16831480